Skip to main content

Patient notice – Tirzepatide (Mounjaro)

We are aware that a message is circulating on local social media suggesting that Tirzepatide (Mounjaro) will be available for weight loss prescriptions from GPs starting 23rd June. As a result, we have received a high volume of enquiries.

Please note that while the guidance refers to ‘primary care’, this does not mean individual GP practices. We have been explicitly advised not to prescribe this medication.

Find out more about Mounjaro (Tirzepatide) access in Cheshire and Merseyside on the ICB website.

About the surgery

  • About us

    Welcome to Berrymead Medical Centre

  • Opening times

    Find out when you can contact the surgery and what to do when we are closed

  • Staff

    Meet the staff working at the surgery

  • Policies

    Find out about the policies our surgery follows

  • Feedback and complaints

    Provide feedback to help improve NHS services or make a complaint

  • Services

    Find out about the range of services available from the surgery

  • Patient Participation Group

    See the latest updates from our Patient Participation Group and how you can join them

  • News

    Read our latest news and other local and national announcements

  • Care Quality Commission (CQC) rating

    Our surgery is inspected by the CQC to ensure we are meeting essential standards of quality and safety

  • Integrated Care Board (ICB)

    Our Integrated Care Board brings together health and care organisations

Page published: 5 May 2023
Last updated: 24 July 2024